Leslie Ablard, MD
Obstetrics · Salina, KSNPI 1932368255
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Pfizer at 32.0% of the total. Reporting peaked in 2021 at $432 and has fallen 55.9% since, to $190 in 2025.
Across 95 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$540
- AbbVie$472
- Astellas Pharma US Inc$114
- Coopersurgical, Inc.$73
- Boston Scientific$55
- Novo Nordisk$50
- plus $386 from 14 others
What the payments were for
- Food & beverage$1,690100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 32 | $540 |
| AbbVie(2 entities) | 25 | $472 |
| Astellas Pharma US Inc | 8 | $114 |
| Coopersurgical, Inc. | 5 | $73 |
| Boston Scientific | 2 | $55 |
| Novo Nordisk | 3 | $50 |
| Conmed Corporation | 1 | $50 |
| Minerva Surgical, Inc | 2 | $47 |
| Organon | 2 | $38 |
| Intuitive Surgical | 1 | $34 |
| Merck | 2 | $33 |
| Evofem Biosciences, Inc. | 2 | $30 |
| Myovant Sciences Inc. | 2 | $30 |
| Hologic Sales And Service, LLC | 2 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Olympus America Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Medtronic | 1 | $11 |
| Bayer | 1 | $11 |
How this compares
Too few obstetrics providers in Kansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OsphenaOspemifene | 12 | $3,318 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $641 |
| Estradiol | 55 | $603 |
| Levothyroxine Sodium | 62 | $467 |
| Atenolol-ChlorthalidoneAtenolol/Chlorthalidone | 11 | $377 |
| Bupropion Hcl SrBupropion Hcl | 15 | $372 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $272 |
| Metoprolol Succinate | 12 | $248 |
| Medroxyprogesterone Acetate | 13 | $232 |
| Propranolol Hcl | 12 | $126 |
| Oxybutynin Chloride | 11 | $89 |
| Fluconazole | 13 | $76 |
| Ibuprofen | 17 | $48 |
| Ciprofloxacin Hcl | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Salina
- Traci NauserOverland Park$5K
- Jennifer LitwinOlathe$4K
- Jessica KiefferTopeka$3K
- James WhiddonWichita$3K
- Jeffrey TeplyTopeka$1K
- Matthew VothWichita$491
- Ericka DomalakesMerriam$60
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.